Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Daniel Welch
Public asset : 1,084,509 USD
Country of residence : Unknown
Linked companies : Waters Corporation

Biography of Daniel Welch 
Presently, Daniel Welch occupies the position of Senior Vice President-Operations at Waters Corp. In the past he occupied the position of Vice President-Operations of Advanced Electron Beams, Inc. and Vice President-Operations at Evergreen Solar, Inc. He received an undergraduate degree from Clarkson University.


Current positions of Daniel Welch 
Holdings of Daniel Welch 
Daniel Welch : Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
RE
05/06MARTIN SORRELL : Sorrell's S4 sees good 2022 after publishing delayed results
RE
More news


© 2022 People and Ownership :   
Daniel Welch : Connections 


Latest news about Daniel Welch 
2021Nuvation Bio, Inc. completed the acquisition of Panacea Acquisition Corp. in a reverse merger transaction.
CI
2020Nuvation Bio, Inc. Announces Management Changes
CI
2020Nuvation Bio, Inc. entered into an agreement to acquire Panacea Acquisition Corp. for $1.7 billion in a reverse merger transaction.
CI
2020TRANSCRIPT : Ultragenyx Pharmaceutical Inc. - Shareholder/Analyst Call
CI
2019TRANSCRIPT : Ultragenyx Pharmaceutical Inc. - Shareholder/Analyst Call
CI
2018TRANSCRIPT : Ultragenyx Pharmaceutical Inc. - Shareholder/Analyst Call
CI
2017TRANSCRIPT : Ultragenyx Pharmaceutical Inc. - Shareholder/Analyst Call
CI
More news